Skip to main content

Table 1 Time course of various dyslipidemia and diabetes markers before and after therapy

From: Severe hypertriglyceridemia in a subject with disturbed life style and poor glycemic control without recurrence of acute pancreatitis: a case report

Dyslipidemia marker

in an emergency room

after 4 days

after 1 month

after interruption of therapy

1 month after treatment restart

1.5 months after treatment restart

Reference range

Total cholesterol (mg/dL)

1055

705

233

1368

131

224

142–248

LDL cholesterol (mg/dL)

240

117

96

490

78

151

65–139

HDL cholesterol (mg/dL)

17

20

34

11

26

31

40–90

Triglyceride (mg/dL)

11,175

5555

675

16,900

298

328

40–149

RLP- cholesterol (mg/dL)

N/A

264.8

N/A

414.9

N/A

15.8

0.0–7.5

Apolipoprotein A-I (mg/dL)

 

121

 

N/A

 

84

119–155

Apolipoprotein A-II (mg/dL)

 

N/A

 

N/A

 

15.1

25.9–35.7

Apolipoprotein B (mg/dL)

 

145

 

N/A

 

140

73–109

Apolipoprotein C-II (mg/dL)

 

N/A

 

N/A

 

9.1

1.8–4.6

Apolipoprotein C-III (mg/dL)

 

N/A

 

N/A

 

11.8

5.8–10.0

Apolipoprotein E (mg/dL)

 

33.4

 

N/A

 

7.0

2.7–4.3

lipoprotein fractions

       

VLDL (%)

 

44

 

52

 

16

3–19

MIDBAND (%)

 

33

 

37

 

24

 

LDL (%)

 

9

 

6

 

46

46–68

HDL (%)

 

11

 

5

 

14

22–74

BAND (%)

 

3

 

 

 

pre-heparin LPL (ng/mL)

 

N/A

 

N/A

 

35

 

Diabetes marker

in an emergency room

after 4 days

after 1 month

after interruption of therapy

1 month after treatment restart

1.5 months after treatment restart

Reference range

Plasma Glucose (mg/dL)

260

N/A

277

310

115

110

73–109

Glycoalbumin (%)

33.5

N/A

25.0

27.8

23.2

21.6

12.4–16.3

Total ketone bodies (μmol/L)

N/A

1275.1

88.6

3870.0

64.8

648.0

0.0–130.0

Acetoacetate (μmol/L)

N/A

524.3

46.8

1610.0

30.9

216.9

0.0–55.0

Beta-hydroxybutylate (μmol/L)

N/A

750.8

41.8

2260.0

33.9

431.1

0.0–85.0

  1. Abbreviation: LDL Low-density lipoproteins, HDL High-density lipoprotein, RLP remnant like particle, LPL lipoprotein lipase
  2. N/A not applicable